{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T20:34:36Z","timestamp":1773434076836,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd001689.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,2,11]],"date-time":"2014-02-11T00:00:00Z","timestamp":1392076800000}}],"reference-count":149,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd001689.pub3","type":"journal-article","created":{"date-parts":[[2014,2,11]],"date-time":"2014-02-11T18:35:07Z","timestamp":1392143707000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period"],"prefix":"10.1002","author":[{"given":"Emily","family":"Bain","sequence":"first","affiliation":[{"name":"The University of Adelaide; ARCH: Australian Research Centre for Health of Women and Babies, The Robinson Institute, Discipline of Obstetrics and Gynaecology; Adelaide South Australia Australia 5006"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnes","family":"Wilson","sequence":"additional","affiliation":[{"name":"The Royal Australian and New Zealand College of Obstetricians and Gynaecologists; 254-260 Albert Street Melbourne Australia 3002"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Tooher","sequence":"additional","affiliation":[{"name":"The University of Adelaide; Discipline of Public Health, School of Population Health; Adelaide South Australia Australia 5006"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Gates","sequence":"additional","affiliation":[{"name":"Division of Health Sciences, Warwick Medical School, The University of Warwick; Warwick Clinical Trials Unit; Gibbet Hill Road Coventry UK CV4 7AL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy-Jane","family":"Davis","sequence":"additional","affiliation":[{"name":"University of Bristol; Department of Social Medicine; 39 Whatley Road Bristol UK BS8 2PS"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippa","family":"Middleton","sequence":"additional","affiliation":[{"name":"The University of Adelaide; ARCH: Australian Research Centre for Health of Women and Babies, The Robinson Institute, Discipline of Obstetrics and Gynaecology; Adelaide South Australia Australia 5006"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,2,11]]},"reference":[{"key":"10.1002\/14651858.CD001689.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0306-5456(00)00198-4","article-title":"A randomised, double blind placebo controlled trial of low molecular weight heparin as prophylaxis in preventing venous thromboembolic events after caesarean section: a pilot study","volume":"108","author":"Burrows","year":"2001","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0004|cit2","unstructured":"Casele H Thrombosis prophylaxis in pregnancy www.enh.org"},{"issue":"6 Suppl","key":"10.1002\/14651858.CD001689.pub3-BIB0002|cit3","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.ajog.2005.10.036","article-title":"Bone density changes in women receiving thromboprophylaxis in pregnancy [abstract]","volume":"193","author":"Casele","year":"2005","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0003|cit4","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.ajog.2006.06.080","article-title":"Bone density changes in women who receive thromboprophylaxis in pregnancy","volume":"195","author":"Casele","year":"2006","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/026835550201700206","article-title":"A randomised trial to compare the effect of pre- or postoperative nandroparin on blood loss during elective caesarean section","volume":"17","author":"Cornette","year":"2002","journal-title":"Phlebology"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0006|cit6","doi-asserted-by":"crossref","unstructured":"Cruz M Fern\u00e1ndez-Alonso A Garrigosa L Cano A Carretero P Vizcaino A Postcesarean thromboprophylaxis with two different regimens of bemiparin [Article ID 548327] Obstetrics and Gynecology International 2011","DOI":"10.1155\/2011\/548327"},{"issue":"6","key":"10.1002\/14651858.CD001689.pub3-BIB0007|cit7","first-page":"S182","article-title":"Dalteparin versus unfractionated heparin for prophylactic anticoagulation during pregnancy [abstract]","volume":"185","author":"Veciana","year":"2001","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1055\/s-0037-1616738","article-title":"Thromboprophylaxis following caesarean section. A comparison of the antithrombotic properties of three low molecular weight heparins - dalteparin, enoxaparin and tinzaparin","volume":"86","author":"Ellison","year":"2001","journal-title":"Thrombosis and Haemostasis"},{"issue":"3","key":"10.1002\/14651858.CD001689.pub3-BIB0009|cit9","first-page":"94","article-title":"Comparisons of the anti-factor XA activities of three commonly used low molecular weight heparins following caesarean section","volume":"45","author":"Ellison","year":"2000","journal-title":"Scottish Medical Journal"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0010|cit10","first-page":"823","article-title":"Thromboprophylaxis following caesarean section: comparison of the anti-factor Xa activities of dalteparin, enoxaparin and tinzaparin","volume":"107","author":"Ellison","year":"2000","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001689.pub3-BIB0011|cit11","first-page":"S39","article-title":"Thromboprophylaxis following caesarean section: comparison of the anti-factor Xa activities of three commonly used low molecular weight heparins","volume":"20","author":"Ellison","year":"2000","journal-title":"Journal of Obstetrics and Gynaecology"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD001689.pub3-BIB0012|cit12","first-page":"S52","article-title":"Randomised controlled trial (PEACH) and meta-analysis of thromboprophylaxis using low-molecular weight heparin (enoxaparin) after caesarean section","volume":"22","author":"Brocklehurst","year":"2002","journal-title":"Journal of Obstetrics and Gynaecology"},{"issue":"Suppl 17","key":"10.1002\/14651858.CD001689.pub3-BIB0013|cit13","first-page":"53","article-title":"Thromboprophylaxis in pregnancy trials: apple, plum and peach","volume":"105","author":"Brocklehurst","year":"1998","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.ajog.2004.03.039","article-title":"Thromboprophylaxis and pregnancy: two randomized controlled pilot trials that used low molecular weight heparin","volume":"191","author":"Gates","year":"2004","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0015|cit15","unstructured":"National Perinatal Epidemiology Unit The PEACH Study www.npeu.ox.ac.uk\/trials\/peach.html"},{"issue":"Suppl 17","key":"10.1002\/14651858.CD001689.pub3-BIB0016|cit16","first-page":"53","article-title":"Thromboprophylaxis in pregnancy trials: apple, plum and peach","volume":"105","author":"Brocklehurst","year":"1998","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.ajog.2004.03.039","article-title":"Thromboprophylaxis and pregnancy: two randomized controlled pilot trials that used low molecular weight heparin","volume":"191","author":"Gates","year":"2004","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD001689.pub3-BIB0018|cit18","first-page":"S44","article-title":"Antenatal thromboprophylaxis using low molecular weight heparin (enoxaparin) for women at risk of thromboembolic disease: multicentre placebo controlled randomised trial (APPLE) and systematic review","volume":"22","author":"Gates","year":"2002","journal-title":"Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0019|cit19","unstructured":"National Perinatal Epidemiology Unit The APPLE Study www.npeu.ox.ac.uk\/trials\/apple.html"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1471-0528.1998.tb10212.x","article-title":"Puerperal thromboprophylaxis: comparison of the anti-Xa activity of enoxaparin and unfractionated heparin","volume":"105","author":"Gibson","year":"1998","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD001689.pub3-BIB0021|cit21","first-page":"S66","article-title":"Low molecular weight heparin is associated with less peripartum blood loss than unfractionated heparin [abstract]","volume":"178","author":"Hamersley","year":"1998","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0022|cit22","first-page":"10","article-title":"Perioperative thrombosis prophylaxis at the time of caesarean section: results of a randomised prospective comparative study with 6% hydroxyethyl starch 0.62 and low dose heparin","volume":"195","author":"Heilman","year":"1991","journal-title":"Zeitschrift fur Geburtshilfe und Perinatologie"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0023|cit23","first-page":"211","article-title":"The rheological changes after cesarean section: the influence of low molecular weight or unfractionated heparin on the rheological properties of blood","volume":"37","author":"Heilmann","year":"2007","journal-title":"Clinical Hemorheology and Microcirculation"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/bmj.296.6635.1505-a","article-title":"Effect of low dose heparin on blood loss at caesarean section","volume":"296","author":"Hill","year":"1988","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0025|cit25","unstructured":"Hill NCW Hill JG Sargent JM Taylor CG Bush PV The effect of low dose heparin on blood loss at caesarean section 12th FIGO World Congress of Gynecology and Obstetrics; 1988 October 23-28; Brazil 1988"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1471-0528.1983.tb06458.x","article-title":"The risks of antenatal subcutaneous heparin prophylaxis: a controlled trial","volume":"90","author":"Howell","year":"1983","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0027|cit27","first-page":"120","article-title":"Use of LMW heparin (Fragmin) for the prevention of thromboembolism in obstetrics","volume":"198","author":"Krauss","year":"1994","journal-title":"Zeitschrift fur Geburtshilfe und Perinatologie"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0028|cit28","unstructured":"O'Riordan MN Horgan R Arya A Quinn S Gaolebale PA Sarkar RK Pharmokinetics of low molecular weight heparins in the postpartum period Irish Perinatal Society Annual Meetings; 2008 April 11-12; Cork, Ireland 2008 10"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0049-3848(99)00110-3","article-title":"Thromboprophylaxis with low molecular weight heparin (dalteparin) in pregnancy","volume":"96","author":"Pettila","year":"1999","journal-title":"Thrombosis Research"},{"issue":"2","key":"10.1002\/14651858.CD001689.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1055\/s-0037-1612970","article-title":"Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin","volume":"87","author":"Pettila","year":"2002","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0028-2243(75)90036-2","article-title":"Prevention of postpartum venous thrombosis with low doses of heparin","volume":"5","author":"Segal","year":"1975","journal-title":"European Journal of Obstetrics and Gynecology and Reproductive Biology"},{"issue":"11","key":"10.1002\/14651858.CD001689.pub3-BIB0032|cit32","first-page":"925","article-title":"Prevention of thromboembolism by physiotherapy with and without low dose heparin in gynecology and obstetrics. Results of a controlled, randomized multicenter study","volume":"101","author":"Welti","year":"1981","journal-title":"Revue Medicale de la Suisse Romande"},{"issue":"3","key":"10.1002\/14651858.CD001689.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/01443610802042688","article-title":"Low-molecular weight heparin in patients with recurrent early miscarriages of unknown aetiology","volume":"28","author":"Badawy","year":"2008","journal-title":"Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00001721-199806000-00006","article-title":"A pharmacokinetic study of dalteparin (Fragmin) during late pregnancy","volume":"9","author":"Blomback","year":"1998","journal-title":"Blood Coagulation and Fibrinolysis"},{"issue":"3","key":"10.1002\/14651858.CD001689.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.fertnstert.2005.03.048","article-title":"Effects of enoxaparin on late pregnancy complications and neonatal outcome in women with recurrent pregnancy loss and thrombophilia: results from the live-enox study","volume":"84","author":"Brenner","year":"2005","journal-title":"Fertility and Sterility"},{"issue":"11","key":"10.1002\/14651858.CD001689.pub3-BIB0036|cit36","first-page":"16a","article-title":"Enoxaparin treatment improves the gestational outcome of pregnant women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study [abstract]","volume":"102","author":"Brenner","year":"2003","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001689.pub3-BIB0037|cit37","first-page":"OC084","article-title":"Efficacy and safety of two doses of enoxaparin in pregnant women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study [abstract]","volume":"1","author":"Brenner","year":"2003","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1538-7836.2004.01090.x","article-title":"Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study","volume":"3","author":"Brenner","year":"2005","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"11 Pt 1","key":"10.1002\/14651858.CD001689.pub3-BIB0039|cit39","first-page":"702a","article-title":"Efficacy and safety of two doses of enoxaparin in pregnant women with thrombophilia and recurrent pregnancy loss. The LIVE-ENOX study [abstract]","volume":"100","author":"Brenner","year":"2002","journal-title":"Blood"},{"issue":"3","key":"10.1002\/14651858.CD001689.pub3-BIB0040|cit40","first-page":"143","article-title":"Safety and effectiveness of tinzaparin sodium in the management of recurrent pregnancy loss","volume":"34","author":"Dendrinos","year":"2007","journal-title":"Clinical and Experimental Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0042|cit41","unstructured":"de Vries JIP Low molecular weight heparin (Fragmin (R)) in pregnant women with a history of uteroplacental insufficiency and thrombophilia, a randomized trial (FRUIT-study) Netherlands Trial Register (http:\/\/www.trialregister.nl)"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0041|cit42","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1538-7836.2011.04553.x","article-title":"Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT","volume":"10","author":"Vries","year":"2012","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"3","key":"10.1002\/14651858.CD001689.pub3-BIB0043|cit43","first-page":"408","article-title":"Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment","volume":"100","author":"Farquharson","year":"2002","journal-title":"Obstetrics and Gynecology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001689.pub3-BIB0044|cit44","first-page":"146","article-title":"Recurrent fetal loss: prospective evaluation of the efficacy of three different thromboprophylaxis regimens: aspirin versus low molecular weight heparin versus low molecular weight heparin plus aspirin [abstract]","volume":"91","author":"Chistolini","year":"2006","journal-title":"Hematology Journal"},{"issue":"7","key":"10.1002\/14651858.CD001689.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3109\/14767058.2011.600366","article-title":"Efficacy of three different antithrombotic regimens on pregnancy outcome in pregnant women affected by recurrent pregnancy loss","volume":"25","author":"Giancotti","year":"2012","journal-title":"Journal of Maternal-Fetal and Neonatal Medicine"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0046|cit46","doi-asserted-by":"crossref","unstructured":"Gris JC Chauleur C Faillie JL Baer G Mares P Fabbro-Peray P Enoxaparin for the secondary prevention of placental vascular complications in women with abruptio placentae: the pilot randomised controlled NOH-AP trial Thrombosis and Haemostasis 2010 771 9","DOI":"10.1160\/TH10-03-0167"},{"issue":"6","key":"10.1002\/14651858.CD001689.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1160\/TH11-05-0340","article-title":"Addition of enoxaparin to aspirin for the secondary prevention of placental vascular complications in women with severe pre-eclampsia: The pilot randomised controlled NOH-PE trial","volume":"106","author":"Gris","year":"2011","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0048|cit48","first-page":"314","article-title":"Lack of anti-factor Xa activity in umbilical cord vein samples after subcutaneous administration of heparin or low molecular mass heparin in pregnant women","volume":"23","author":"Harenberg","year":"1993","journal-title":"Haemostasis"},{"issue":"17","key":"10.1002\/14651858.CD001689.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1056\/NEJMoa1000641","article-title":"Aspirin plus heparin or aspirin alone in women with recurrent miscarriage","volume":"362","author":"Kaandorp","year":"2010","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0050|cit50","unstructured":"Middeldorp S Aspirin and\/or low molecular weight heparin for women with unexplained recurrent miscarriage and\/or intra-uterine fetal death Netherlands Trial Register (http:\/\/www.trialregister.nl)"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1055\/s-0028-1088777","article-title":"Therapy with dalteparin for habitual abortion - presentation of the ETHiG II-Studie","volume":"68","author":"Kamin","year":"2008","journal-title":"Geburtshilfe und Frauenheilkunde"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001689.pub3-BIB0052|cit52","first-page":"S220","article-title":"Low molecular weight heparin for the prevention of habitual abortion - introduction of the multicentre study EThIG2 and discussion of the current data","volume":"286","author":"Schleussner","year":"2012","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001689.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/S0049-3848(13)70035-5","article-title":"Low-molecular-weight heparin in recurrent pregnancy loss-Results of the ETHIG II study","volume":"131","author":"Schleussner","year":"2013","journal-title":"Thrombosis Research"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1600-0897.1996.tb00501.x","article-title":"A clinical trial for the treatment of antiphospholipid antibody-associated recurrent pregnancy loss with lower dose heparin and aspirin","volume":"35","author":"Kutteh","year":"1996","journal-title":"American Journal of Reproductive Immunology"},{"issue":"5","key":"10.1002\/14651858.CD001689.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/S0002-9378(96)70610-5","article-title":"Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone","volume":"174","author":"Kutteh","year":"1996","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD001689.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.fertnstert.2004.11.002","article-title":"Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin","volume":"83","author":"Noble","year":"2005","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0057|cit57","first-page":"ii212","article-title":"Influence of enoxaparine on serum endotoxin concentration in puerpera after abdominal delivery","volume":"108","author":"Pyregov","year":"2012","journal-title":"British Journal of Anaesthesia"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0058|cit58","first-page":"44","article-title":"Randomized trial of aspirin versus aspirin and heparin in pregnant women with the antiphospholipid syndrome","volume":"147 Suppl 1","author":"Cohen","year":"1996","journal-title":"Annales de Medicine Interne"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.314.7076.253","article-title":"Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)","volume":"314","author":"Rai","year":"1997","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD001689.pub3-BIB0060|cit60","first-page":"795","article-title":"Compression and walking compared with bed rest in the treatment of proximal deep venous thrombosis during pregnancy","volume":"113","author":"Ratiu","year":"2009","journal-title":"Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD001689.pub3-BIB0062|cit61","first-page":"S46","article-title":"Dalteparin in prevention of recurrence of severe obstetrical complications in women without thrombophilia","volume":"29","author":"Rey","year":"2007","journal-title":"Journal of Obstetrics and Gynaecology Canada"},{"issue":"1","key":"10.1002\/14651858.CD001689.pub3-BIB0061|cit62","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1538-7836.2008.03230.x","article-title":"Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial","volume":"7","author":"Rey","year":"2009","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"8","key":"10.1002\/14651858.CD001689.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S1701-2163(16)30644-2","article-title":"Treatment of antiphospholipid antibody syndrome (aps) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin","volume":"26","author":"Stephenson","year":"2004","journal-title":"Journal of Obstetrics and Gynaecology Canada"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD001689.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.ajog.2004.09.049","article-title":"Efficacy of enoxaparin for improving pregnancy outcomes and uteroplacental blood flow in women with thrombophilia and recurrent pregnancy loss [abstract]","volume":"191","author":"Thaler","year":"2004","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"7","key":"10.1002\/14651858.CD001689.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1093\/humrep\/12.7.1567","article-title":"Low-dose aspirin in prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect of prostacyclin and thromboxane A2 production","volume":"12","author":"Tulppala","year":"1997","journal-title":"Human Reproduction"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001689.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"S371","DOI":"10.1016\/S0020-7292(09)61351-5","article-title":"A randomised controlled multicenter study: the effect of enoxaparin and\/or aspirin on prevention of recurrent miscarriage in women with or without thrombophilia, HABENOX-study","volume":"107","author":"Visser","year":"2009","journal-title":"International Journal of Gynecology and Obstetrics"},{"issue":"2","key":"10.1002\/14651858.CD001689.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1160\/TH10-05-0334","article-title":"Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia - HABENOX*: a randomised multicentre trial","volume":"105","author":"Visser","year":"2011","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0068|cit68","first-page":"A40","article-title":"Prevention of deep vein thrombosis (DVT) in pregnancy, after caesarean section and after gynaecological abdominal surgery. A comparison between low molecular weight heparin (LMW) and standard heparin (UFH) [abstract]","volume":"62 Suppl 1","author":"Dittmer","year":"1991","journal-title":"Annals of Haematology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD001689.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"S796","DOI":"10.1016\/S0020-7292(12)62002-5","article-title":"The risk of venous thromboembolism and its prevention in obstetrics","volume":"119","author":"Nagornaya","year":"2012","journal-title":"International Journal of Gynecology and Obstetrics"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0070|cit70","unstructured":"NCT00225108 The STOP CLOT pilot study: study of low molecular weight heparin in high risk postpartum women following cesarean section (ongoing trial) http:\/\/clinicaltrials.gov\/show\/NCT00225108"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0071|cit71","unstructured":"NCT00878826 Prophylactic enoxaparin dosing for prevention of venous thromboembolism in pregnancy http:\/\/clinicaltrials.gov\/ct2\/show\/record\/NCT00878826"},{"issue":"1","key":"10.1002\/14651858.CD001689.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1160\/TH06-10-0574","article-title":"The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia. A randomized trial","volume":"98","author":"Abou-Nassar","year":"2007","journal-title":"Thrombosis and Haemostasis"},{"issue":"11 Pt 1","key":"10.1002\/14651858.CD001689.pub3-BIB0073|cit73","first-page":"262","article-title":"The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia: a randomised trial","volume":"108","author":"Abou-Nassar","year":"2006","journal-title":"Blood"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0074|cit74","unstructured":"NCT00967382 Thrombophilia in pregnancy prophylaxis study (TIPPS) http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT00967382"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001689.pub3-BIB0075|cit75","first-page":"8","article-title":"Prophylactic low molecular weight heparin (LMWH) during pregnancy is not associated with a decrease in bone mineral density (BMD) [abstract]","volume":"25","author":"Rodger","year":"2006","journal-title":"Hypertension in Pregnancy"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1111\/j.1538-7836.2007.02634.x","article-title":"Long-term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial","volume":"5","author":"Rodger","year":"2007","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"11","key":"10.1002\/14651858.CD001689.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"Abstract No 548","DOI":"10.1182\/blood.V106.11.548.548","article-title":"Prophylactic low molecular weight heparin (LMWH) during pregnancy is not associated with a decrease in bone mineral density (BMD). The TIPPS (Thrombophilia in Pregnancy Prophylaxis Study) BMD substudy","volume":"106","author":"Rodger","year":"2005","journal-title":"Blood"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0078|cit78","unstructured":"NCT01019655 Heparin for pregnant with thrombophilia http:\/\/clinicaltrials.gov\/show\/NCT01019655"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0079|cit79","unstructured":"NCT01068795 Dose adjusting enoxaparin thromboprophylaxis dosage according to anti-factor Xa plasma levels improve pregnancy outcome http:\/\/clinicaltrials.gov\/show\/NCT01068795"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0080|cit80","unstructured":"NCT01274637 PROSPER: Postpartum prophylaxis for PE randomized control trial pilot http:\/\/clinicaltrials.gov\/show\/NCT01274637"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0081|cit81","unstructured":"NCT01793194 Preventing the development of venous insufficiency in pregnant women through use of compression stockings: a randomized pilot study http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01793194"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0082|cit82","unstructured":"NCT01828697 Low-molecular-weight heparin to prevent recurrent VTE in pregnancy: a randomized controlled trial of two doses http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01828697"},{"issue":"3","key":"10.1002\/14651858.CD001689.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/AOG.0b013e3182310c4c","article-title":"Thromboembolism in pregnancy practice bulletin","volume":"118","author":"The American College of Obstetricians and Gynecologists (ACOG) Committee on Practice Bulletins-Obstetrics","year":"2011","journal-title":"Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD001689.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0301-2115(01)00496-1","article-title":"How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review","volume":"101","author":"Alfirevic","year":"2002","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"issue":"3","key":"10.1002\/14651858.CD001689.pub3-BIB0085|cit85","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003747.pub3","article-title":"Heparin for the prevention of venous thromboembolism in general medical patients (excluding stroke and myocardial infarction)","author":"Alikhan","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1080\/j.1600-0412.1998.770207.x","article-title":"The cumulative incidence of venous thromboembolism during pregnancy and puerperium - an 11 year Danish population - based study of 63,300 pregnancies","volume":"77","author":"Andersen","year":"1998","journal-title":"Acta Obstetricia et Gynecologia Scandinavica"},{"issue":"2","key":"10.1002\/14651858.CD001689.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0049-3848(96)00057-6","article-title":"Thrombin-inhibitor complexes in the blood during and after delivery","volume":"82","author":"Andersson","year":"1996","journal-title":"Thrombosis Research"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001689.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-200464001-00002","article-title":"Current options in the prevention of thromboembolic disease","volume":"64","author":"Ansell","year":"2004","journal-title":"Drugs"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1365-2141.2011.08684.x","article-title":"How I manage venous thromboembolism in pregnancy","volume":"153","author":"Arya","year":"2011","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0090|cit90","first-page":"1055","article-title":"Maternal morbidity in the United States 1979-1986","volume":"76","author":"Atrash","year":"1990","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0889-8545(05)70319-3","article-title":"Current concepts of anticoagulant therapy in pregnancy","volume":"24","author":"Barbour","year":"1997","journal-title":"Obstetrics and Gynecology Clinics of North America"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"844S","DOI":"10.1378\/chest.08-0761","article-title":"Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy","volume":"133","author":"Bates","year":"2008","journal-title":"Chest"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001689.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/S0049-3848(09)70010-6","article-title":"Treatment of venous thromboembolism during pregnancy","volume":"123","author":"Bauersachs","year":"2009","journal-title":"Thrombosis Research"},{"issue":"10","key":"10.1002\/14651858.CD001689.pub3-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1046\/j.1538-7836.2003.00504.x","article-title":"Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications--Yes","volume":"1","author":"Brenner","year":"2003","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1056\/NEJM200011163432002","article-title":"Safety of withholding heparin in pregnant women with a history of venous thromboembolism","volume":"343","author":"Brill-Edwards","year":"2000","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0096|cit96","doi-asserted-by":"crossref","unstructured":"Centre for Maternal and Child Enquiries (CMACE) Saving Mothers\u2019 Lives. Reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom British Journal of Obstetrics and Gynaecology 2011 1 203","DOI":"10.1111\/j.1471-0528.2010.02847.x"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1055\/s-0038-1645218","article-title":"Thrombosis and pregnancy in congenital deficiencies of AT III, Protein C or Protein S: study of 78 women","volume":"63","author":"Conard","year":"1990","journal-title":"Thrombosis and Haemostasis"},{"issue":"3","key":"10.1002\/14651858.CD001689.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-2141.2006.06317.x","article-title":"The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis","volume":"135","author":"Stefano","year":"2006","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0099|cit99","article-title":"Why mothers die","volume-title":"Report of the Confidential Enquiries into Maternal Deaths 1994-1996","author":"Department of Health","year":"1998"},{"issue":"6","key":"10.1002\/14651858.CD001689.pub3-BIB0100|cit100","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006780.pub2","article-title":"Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction","author":"Dodd","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD001689.pub3-BIB0101|cit101","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002859.pub2","article-title":"Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant","author":"Empson","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"955","DOI":"10.7326\/0003-4819-125-12-199612150-00003","article-title":"Frequency of pregnancy-related venous thromboembolism in anticoagulant factor deficient women: implications for prophylaxis","volume":"125","author":"Friederich","year":"1996","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0103|cit103","first-page":"730","article-title":"Incidence, clinical characteristics and timing of objectively diagnosed venous thromboembolism during pregnancy","volume":"94","author":"Gherman","year":"1999","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0140-6736(11)61904-1","article-title":"Pulmonary embolism and deep vein thrombosis","volume":"379","author":"Goldhaber","year":"2012","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"55-84","DOI":"10.1016\/B978-0-443-06930-7.50005-0","article-title":"Maternal physiology","volume-title":"Obstetrics: Normal and Problem Pregnancies","author":"Gordon","year":"2007"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0106|cit106","first-page":"203","article-title":"Thrombosis in pregnancy: updates in diagnosis and management","volume":"2012","author":"Greer","year":"2012","journal-title":"Hematologic Diseases in Pregnancy"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0002-9343(80)90181-3","article-title":"Maternal and fetal sequelae of anticoagulation during pregnancy","volume":"68","author":"Hall","year":"1980","journal-title":"American Journal of Medicine"},{"issue":"10","key":"10.1002\/14651858.CD001689.pub3-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-143-10-200511150-00006","article-title":"Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study","volume":"143","author":"Heit","year":"2005","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0109|cit109","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"c95","DOI":"10.1136\/bmj.c95","article-title":"Reducing the risk of venous thromboembolism in patients admitted to hospital: summary of NICE guidance","volume":"340","author":"Hill","year":"2010","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0111|cit111","first-page":"240","article-title":"Maternal mortality in Sweden, 1980-1988","volume":"84","author":"H\u00f6gberg","year":"1994","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"1311-5","DOI":"10.1016\/j.ajog.2005.11.008","article-title":"Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality","volume":"194","author":"James","year":"2006","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD001689.pub3-BIB0113|cit113","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004734.pub3","article-title":"Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome","author":"Kaandorp","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD001689.pub3-BIB0114|cit114","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005258.pub2","article-title":"Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients","author":"Kakkos","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD001689.pub3-BIB0115|cit115","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000492.pub2","article-title":"Antiplatelet agents for preventing and treating pre-eclampsia","author":"Knight","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1471-0528.2007.01622.x","article-title":"Antenatal pulmonary embolism: risk factors,management and outcomes. UKOSS","volume":"115","author":"Knight","year":"2008","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1067\/mob.2000.105405","article-title":"The prevalence of thromboembolic events among women with extended bed rest prescribed as part of the treatment for premature labor or preterm premature rupture of membranes","volume":"182","author":"Kovacevich","year":"2000","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD001689.pub3-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1447-0756.2007.00550.x","article-title":"Single inherited thrombophilias and adverse pregnancy outcomes","volume":"33","author":"Larciprete","year":"2007","journal-title":"Journal of Obstetrics and Gynaecology Research"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0950-3552(97)80026-0","article-title":"Peripartum prophylaxis of thrombo-embolism","volume":"11","author":"Letsky","year":"1997","journal-title":"Bailliere's Clinical Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0120|cit120","volume-title":"Why mothers die, 2000-2002. The Sixth Report of Confidential Enquiries into Maternal Deaths in the United Kingdom","author":"Lewis","year":"2004"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0121|cit121","first-page":"348","article-title":"Late venous function in the leg after deep venous thrombosis occurring in relation to pregnancy","volume":"93","author":"Lindhagen","year":"1986","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0122|cit122","first-page":"595","article-title":"Thrombotic risk during pregnancy: a population study","volume":"94","author":"Lindqvist","year":"1999","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.thromres.2012.01.017","article-title":"Pregnancy-related venous thromboembolism: Risk and the effect of thromboprophylaxis","volume":"129","author":"Lussana","year":"2012","journal-title":"Thrombosis Research"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/003693309604100305","article-title":"Venous thromboembolic disease in obstetrics and gynaecology: the Scottish experience","volume":"41","author":"Macklon","year":"1996","journal-title":"Scottish Medical Journal"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1471-0528.1997.tb11043.x","article-title":"An ultrasound study of gestational and postural changes in the deep venous system of the leg in pregnancy","volume":"104","author":"Macklon","year":"1997","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1479-828X.2011.01357.x","article-title":"Recommendations for the prevention of pregnancy-associated venous thromboembolism","volume":"52","author":"McLintock","year":"2012","journal-title":"Australian and New Zealand Journal of Obstetrics and Gynaecology"},{"issue":"10","key":"10.1002\/14651858.CD001689.pub3-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1046\/j.1538-7836.2003.00503.x","article-title":"Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications--No","volume":"1","author":"Middeldorp","year":"2003","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0950-3552(97)80024-7","article-title":"Hazards of heparin: allergy, heparin-induced thrombocytopenia and osteoporosis","volume":"11","author":"Nelson-Piercy","year":"1997","journal-title":"Bailliere's Clinical Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0129|cit129","article-title":"Clinical practice guideline for the prevention of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to Australian hospitals.","volume-title":"Clinical practice guideline for the prevention of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to Australian hospitals","author":"National Health and Medical Research Council","year":"2009"},{"issue":"6","key":"10.1002\/14651858.CD001689.pub3-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1089\/jwh.2012.3600","article-title":"Prevention of venous thromboembolism in pregnancy: a review of guidelines, 2000-2011","volume":"21","author":"Okoroh","year":"2012","journal-title":"Journal of Women's Health"},{"issue":"6076","key":"10.1002\/14651858.CD001689.pub3-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1136\/bmj.1.6076.1564","article-title":"May mothers given warfarin breast-feed their infants?","volume":"1","author":"Orme","year":"1977","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1182\/blood-2002-01-0149","article-title":"Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism","volume":"100","author":"Pabinger","year":"2002","journal-title":"Blood"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/0310057X8701500208","article-title":"A prospective study of dextran-induced anaphylactoid reactions in 5745 patients","volume":"15","author":"Paull","year":"1987","journal-title":"Anaesthesia and Intensive Care"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0140-6736(00)02110-3","article-title":"Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin","volume":"355","author":"PEP Trial Collaborative Group","year":"2000","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD001689.pub3-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2008.02921.x","article-title":"Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study","volume":"6","author":"Pomp","year":"2008","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"4","key":"10.1002\/14651858.CD001689.pub3-BIB0136|cit136","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005259.pub3","article-title":"Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy","author":"Ramos","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0137|cit137","volume-title":"Reducing the risk of thrombosis and embolism during pregnancy and the puerperium. Green-top Guideline No. 37","author":"Royal College of Obstetricians and Gynaecologists (RCOG)","year":"2009"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0138|cit138","unstructured":"The Nordic Cochrane Center, The Cochrane Collaboration Review Manager (RevMan) 2012"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2141.2005.05847.x","article-title":"Thrombophilia in pregnancy: a systematic review. Thrombosis: Risk and Economic Assessment of Yhrombophilia Screening (TREATS) Study","volume":"132","author":"Robertson","year":"2006","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/0002-9378(91)90879-V","article-title":"Thromboembolic disease associated with pregnancy: an 11 year review","volume":"164","author":"Rutherford","year":"1991","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD001689.pub3-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0306-5456(00)00004-8","article-title":"Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database","volume":"108","author":"Simpson","year":"2001","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2141.2011.08956.x","article-title":"Risk of first venous thromboembolism in and around pregnancy:a population-based cohort study","volume":"156","author":"Sultan","year":"2011","journal-title":"British Journal of Haematology"},{"issue":"4","key":"10.1002\/14651858.CD001689.pub3-BIB0143|cit143","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006681.pub2","article-title":"Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-leg immobilization","author":"Testroote","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD001689.pub3-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1160\/TH10-12-0823","article-title":"Venous thromboembolism in pregnant and puerperal women in Denmark 1995-2005. A national cohort study","volume":"106","author":"Virkus","year":"2011","journal-title":"Thrombosis and Haemostasis"},{"issue":"2","key":"10.1002\/14651858.CD001689.pub3-BIB0145|cit145","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003580","article-title":"Heparin for pregnant women with acquired or inherited thrombophilias","author":"Walker","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD001689.pub3-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1365-2141.2005.05715.x","article-title":"Screening for thrombophilia in high-risk situations: a meta-analysis and cost-effectiveness analysis","volume":"131","author":"Wu","year":"2005","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD001689.pub3-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejogrb.2012.12.022","article-title":"Current obstetric guidelines on thromboprophylaxis in the United Kingdom:evidence based medicine?","volume":"168","author":"Wu","year":"2013","journal-title":"European Journal of Obstetrics and Gynecology and Reproductive Biology"},{"issue":"2","key":"10.1002\/14651858.CD001689.pub3-BIB0148|cit148","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001689","article-title":"Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period","author":"Gates","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD001689.pub3-BIB0149|cit149","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001689.pub2","article-title":"Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period","author":"Tooher","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd001689.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T00:00:00Z","timestamp":1616976000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD001689.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:04:23Z","timestamp":1628543063000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD001689.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Pregnancy and Childbirth Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,2,11]]},"references-count":149,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001689.pub3","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD001689.pub4","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,11]]}}}